| Original language | English (US) |
|---|---|
| Pages (from-to) | 1224-1226.e9 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 143 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2019 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Allergy and Clinical Immunology, Vol. 143, No. 3, 03.2019, p. 1224-1226.e9.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Peak flow variability in childhood and body mass index in adult life
AU - Lombardi, Enrico
AU - Stern, Debra A.
AU - Sherrill, Duane
AU - Morgan, Wayne J.
AU - Wright, Anne L.
AU - Garcia-Aymerich, Judith
AU - Serra Pons, Ignasi
AU - Guerra, Stefano
AU - Martinez, Fernando D.
N1 - Funding Information: Disclosure of potential conflict of interest: S. Guerra, A. L. Wright, D. A. Stern, W. J. Morgan, and F. D. Martinez received support for this research from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) (grant no. 132523). E. Lombardi has received fees or travel grants during the past 5 years from Angelini, Boehringer, Chiesi, Lusofarmaco, Omron, Vertex Pharmaceuticals, and Vifor. S. Guerra reports grants from NIH/NHLBI, NIH/National Institute of Allergy and Infectious Diseases (NIAID), and the Cystic Fibrosis Foundation. W. J. Morgan reports grants from NIH/NHLBI, NIH/NIAID, and the Cystic Fibrosis Foundation; personal fees from the Cystic Fibrosis Foundation; and personal fees from Genentech. F. D. Martinez reports grants from NIH/NHLBI, NIH/NIAID, NIH/National Institute of Environmental Health Sciences, NIH/Office of the Director, and Johnson & Johnson. He was also a consultant for Commense INC and Copeval. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: Disclosure of potential conflict of interest: S. Guerra, A. L. Wright, D. A. Stern, W. J. Morgan, and F. D. Martinez received support for this research from the National Institutes of Health (NIH)/ National Heart, Lung, and Blood Institute (NHLBI) (grant no. 132523 ). E. Lombardi has received fees or travel grants during the past 5 years from Angelini, Boehringer, Chiesi, Lusofarmaco, Omron, Vertex Pharmaceuticals, and Vifor. S. Guerra reports grants from NIH/ NHLBI , NIH/ National Institute of Allergy and Infectious Diseases (NIAID), and the Cystic Fibrosis Foundation . W. J. Morgan reports grants from NIH/ NHLBI , NIH/ NIAID , and the Cystic Fibrosis Foundation; personal fees from the Cystic Fibrosis Foundation; and personal fees from Genentech. F. D. Martinez reports grants from NIH/ NHLBI , NIH/ NIAID , NIH/ National Institute of Environmental Health Sciences , NIH/ Office of the Director , and Johnson & Johnson . He was also a consultant for Commense INC and Copeval. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: This study was supported by the National Heart, Lung, and Blood Institute (grant no. 132523 ). Funding Information: This study was supported by the National Heart, Lung, and Blood Institute (grant no. 132523).Disclosure of potential conflict of interest: S. Guerra, A. L. Wright, D. A. Stern, W. J. Morgan, and F. D. Martinez received support for this research from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) (grant no. 132523). E. Lombardi has received fees or travel grants during the past 5 years from Angelini, Boehringer, Chiesi, Lusofarmaco, Omron, Vertex Pharmaceuticals, and Vifor. S. Guerra reports grants from NIH/NHLBI, NIH/National Institute of Allergy and Infectious Diseases (NIAID), and the Cystic Fibrosis Foundation. W. J. Morgan reports grants from NIH/NHLBI, NIH/NIAID, and the Cystic Fibrosis Foundation; personal fees from the Cystic Fibrosis Foundation; and personal fees from Genentech. F. D. Martinez reports grants from NIH/NHLBI, NIH/NIAID, NIH/National Institute of Environmental Health Sciences, NIH/Office of the Director, and Johnson & Johnson. He was also a consultant for Commense INC and Copeval. The rest of the authors declare that they have no relevant conflicts of interest.
PY - 2019/3
Y1 - 2019/3
UR - http://www.scopus.com/inward/record.url?scp=85057603306&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057603306&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2018.10.035
DO - 10.1016/j.jaci.2018.10.035
M3 - Article
C2 - 30414860
AN - SCOPUS:85057603306
SN - 0091-6749
VL - 143
SP - 1224-1226.e9
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 3
ER -